Rhône Capital acquisition of Invacare
We advised Highbridge Capital, as an Invacare secured lender and noteholder, on the transaction
Experience
To find Davis Polk deals and cases of particular interest, select filters based on practice, industry, region, lawyer and keyword.
Filters
LXO Group hybrid capital acquisition financing
We advised Hayfin Capital Management on its hybrid capital investment in LXO Group
Penumbra $14.5 billion sale to Boston Scientific
We are advising Penumbra on the transaction
W. L. Gore & Associates acquisition of Conformal Medical
We are advising Gore on the transaction
LifeScan emerges from chapter 11
We advised an ad hoc group of secured lenders in connection with LifeScan’s chapter 11 proceedings
Novo Nordisk proposed $9.1 billion acquisition of Metsera
We are advising Novo Nordisk on the transaction
Amulet Capital Partners sale of SSI Strategy to Clinigen
We are advising Amulet Capital Partners and SSI Strategy on the sale
Strive acquisition of Semler Scientific
We are advising Strive on the acquisition
UST sale of HealthProof to Bain
We advised UST on the transaction
Sycamore Partners up to $23.7 billion acquisition of Walgreens Boots Alliance
We advised Sycamore Partners on the transaction